1-3 of 3
Qing Xiao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2 Study of Golidocitinib, a JAK1 Selective Inhibitor, As Maintenance Therapy in Patients with Peripheral T Cell Lymphomas after First-Line Systemic Therapy (JACKPOT26)

Jie Jin, Qingqing Cai, Liling Zhang, Liqun Zou, Zengjun Li, Huijing Wu, Keshu Zhou, Lihua Qiu, Liping Su, Kaiyang Ding, Hui Zhou, Li Yu, Fei Li, Qing Xiao, Wenyu Li, Lie Lin, Erhua Wang, Lijia Chen
Journal: Blood
Blood (2023) 142 (Supplement 1): 4430.
https://doi.org/10.1182/blood-2023-185543
Published: 2023
Journal Articles

Combination of Mitoxantrone Hydrochloride Liposome with Cyclophosphamide, Vincristine and Prednisone (CMOP) in Treatment-Naïve Patients with Peripheral T-Cell Lymphoma: A Multicenter, Open-Label, Single-Arm, Phase Ib Clinical Trial

Hui-Qiang Huang, Gao Yan, Ming Jiang, Lihong Liu, Qing Xiao, Yufu Li, Hui Zhou, Jianfei Xue, Dong Wang, Dapeng Xie, Honglian Li, Peng Wang
Journal: Blood
Blood (2022) 140 (Supplement 1): 3762–3763.
https://doi.org/10.1182/blood-2022-163343
Published: 2022
Journal Articles

Growth and Dissemination of Lewis Lung Carcinoma in Plasminogen-Deficient Mice

Thomas H. Bugge, Keith W. Kombrinck, Qing Xiao, Kenn Holmbäck, Cynthia C. Daugherty, Dave P. Witte, Jay L. Degen
Journal: Blood
Blood (1997) 90 (11): 4522–4531.
https://doi.org/10.1182/blood.V90.11.4522
Published: 1997